Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.4457
Abstract: Importance Racial and ethnic minority and socioeconomically disadvantaged patients have been underrepresented in randomized clinical trials. Efforts have focused on enhancing inclusion of minority groups at sites participating at clinical trials; however, there may be… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29324
Abstract: Redo surgical mitral valve replacement (SMVR) is the current standard of care for patients with failed bioprosthetic mitral valve (MV). Transcatheter mitral valve‐in‐valve replacement (TMViV) is arising as an alternative to SMVR in high risk… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29390
Abstract: Little is known about the association of heart failure (HF) chronicity with clinical outcomes after transcatheter mitral valve repair (TMVR) for functional mitral regurgitation (MR). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30057
Abstract: To assess the impact of pulmonary hypertension (PH) on outcomes of patients with severe mitral annular calcification (MAC) undergoing transcatheter mitral valve replacement (TMVR). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30059
Abstract: Transcatheter mitral valve replacement (TMVR) has emerged as a feasible alternative to redo surgical mitral valve replacement (SMVR) in patients with degenerated mitral prostheses, with limited comparative data. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30196
Abstract: Mitral valve regurgitation (MR) affects nearly 10% of adults over the age of 75 and is the leading cause of valvular disease in Western countries. 1 Although surgical repair or replacement remains the standard of… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30238
Abstract: To evaluate the safety and efficacy of transcatheter mitral valve repair (TMVR) in patients with chronic obstructive pulmonary disease (COPD). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30471
Abstract: In the current study, we assess the predictive role of right and left atrial volume indices (RAVI and LAVI) as well as the ratio of RAVI/LAVI (RLR) on mortality following transcatheter mitral valve repair (TMVr). read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2203
Abstract: Mitral regurgitation (MR) is the most frequent heart valve disease in the community and the second most frequent cause of hospital referral.1–3 The distinction between primary and secondary MR is of utmost importance since they… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2492
Abstract: Transcatheter mitral valve implantation (TMVI) represents a novel treatment option for patients with mitral regurgitation (MR) unsuitable for established therapies. The CHOICE‐MI registry aimed to investigate outcomes of patients undergoing screening for TMVI. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2797
Abstract: This study aimed to compare outcomes after transcatheter mitral valve replacement (TMVR) and mitral valve transcatheter edge‐to‐edge repair (M‐TEER) for the treatment of secondary mitral regurgitation (SMR). read more here.